PMI

The Cancer Drugs Fund has led to a ‘devastating divide' in access to treatment between England and other home nations, according to a cancer charity.

A long-term plan to provide more US citizens with health insurance may fall short of hitting its targets as it is still too expensive for a lot of people, according to reports.

The private healthcare market ‘may not be working well for consumers', the Office of Fair Trading (OFT) has said.

Unison has called for an immediate halt to the government's Health and Social Care Bill that will reform the NHS and highlighted fears that private patients may get priority.

The National Institute for Health and Clinical Excellence (NICE) has rejected another cancer drug for the NHS due to its cost.

The NHS exceeded all seven of its targets for cancer diagnosis and treatment during the last year, new data has revealed.

The NHS Future Forum is to conduct a second stage of its listening exercise following a request by the government to assess its revised proposals.

The NHS is in good financial health after producing a surplus of £1.5bn over the last financial year but it faces a stiff challenge over the coming years.

The NHS has revealed 9,000 more patients in England had waited more than six weeks for key diagnostic tests compared to the same time last year.

Bupa's half year results have shown the international healthcare group's revenue up 6% to £3.9bn.